ArticleOncoTargets and therapy2019

Therapeutic Effect Of First-Line EGFR-TKIs Combined With Concurrent Cranial Radiotherapy On NSCLC Patients With EGFR Activating Mutation And Brain Metastasis: A Retrospective Study.

Ning An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.